Department of Gastroenterology, Dokkyo Medical University, 880 Kitakobayashi, Mibu 321-0293, Japan.
Medicina (Kaunas). 2022 Feb 11;58(2):276. doi: 10.3390/medicina58020276.
A 41-year-old man was treated with prednisolone (PSL) and multimatrix (MMX) mesalamine for remission induction therapy of ulcerative colitis. PSL was tapered due to successful remission induction treatment. During the treatment course, ocular foreign body sensation, eyelid swelling, ocular conjunctiva hyperemia, facial redness and swelling, watery nasal discharge, stomatitis, anal pain, and reddish puffiness on the bilateral dorsum of the hands appeared, and he was diagnosed with Stevens-Johnson syndrome (SJS). SJS was improved by PSL treatment and intravenous immunoglobulin. MMX mesalamine was the causative agent by drug-induced lymphocyte stimulation test. This is the first reported case of SJS with MMX mesalamine.
一位 41 岁男性因溃疡性结肠炎的缓解诱导治疗而接受泼尼松龙(PSL)和多基质(MMX)美沙拉嗪治疗。由于缓解诱导治疗成功,PSL 逐渐减量。在治疗过程中,出现眼部异物感、眼睑肿胀、眼结膜充血、面部发红肿胀、水样鼻涕、口腔炎、肛门疼痛,以及双手背双侧出现红色肿胀,被诊断为 Stevens-Johnson 综合征(SJS)。PSL 治疗和静脉注射免疫球蛋白改善了 SJS。药物诱导的淋巴细胞刺激试验表明 MMX 美沙拉嗪是致病药物。这是首例报道的 SJS 合并 MMX 美沙拉嗪的病例。